PAYX vs SABSW · P/E 22, rev $6.51B vs P/E 0.0
Paychex Inc (PAYX) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
SABSW does not have a complete income-statement cache yet.
PAYX currently screens at market cap $34.96B and trailing P/E 21.5. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the PAYX and SABSW stock pages for the full models.
Not investment advice.